
Scientists Revive 160-Million-Year-Old Proteins to Fight Superbugs
University of Oregon researchers brought ancient immune proteins back to life and discovered some work better than modern versions against drug-resistant bacteria. The breakthrough could lead to new weapons in the fight against superbugs that no longer respond to antibiotics.
Scientists just turned evolution into a time machine, and what they found could save millions of lives threatened by antibiotic-resistant infections.
Researchers at the University of Oregon resurrected proteins up to 160 million years old, dating back to the earliest ancestors of mammals. These ancient immune proteins, tested in labs, proved surprisingly effective at killing modern drug-resistant bacteria.
The team focused on lactoferrin, a protein found in breast milk, tears, and saliva that fights infections by starving bacteria of iron and punching holes in their membranes. Lead researcher Titas Sil compared gene sequences across species like humans and cows, then worked backward to recreate what those proteins looked like millions of years ago.
The results surprised everyone. Some ancient versions outperformed their modern human counterparts against dangerous pathogens like E. coli and Staphylococcus aureus.
"Evolution is essentially a billions-year-old science experiment," said Matt Barber, the study's senior author. The key difference came down to tiny changes: a single mutation in the protein structure made some ancient peptides far more lethal to bacteria.

The discovery matters because antibiotic resistance threatens to undo one of medicine's greatest achievements. Bacteria are evolving faster than scientists can create new drugs, making once-treatable infections deadly again.
The Ripple Effect
This prehistoric approach opens an entirely new path for drug development. Instead of only looking forward, scientists can now mine evolution's four-billion-year experiment for solutions nature already tested.
The method, called ancestral sequence reconstruction, essentially gives researchers access to millions of genetic prototypes that worked well enough to survive eons of natural selection. Some of these extinct versions possess qualities modern biology lost along the way.
Clinical trials have already tested derivatives of human lactoferrin peptides. Now researchers know that small evolutionary tweaks could make them significantly more powerful.
The team cautions that new drugs won't appear overnight. These peptides break down quickly in the body, making them trickier to use than conventional antibiotics. But understanding how antimicrobial weapons evolved naturally gives scientists a blueprint for designing treatments bacteria can't easily defeat.
The research, published in PLOS Biology, proves that sometimes the best way forward is looking back. Nature spent millions of years perfecting these molecular warriors, and now modern medicine gets to learn from that ancient wisdom.
Based on reporting by Google News - New Treatment
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


